Login to Your Account

Washington Roundup

Will the Supreme Court Grant Cert in Myriad Patent Case?

By Mari Serebrov
Washington Editor

Thursday, February 16, 2012
WASHINGTON – The Supreme Court is set to consider Friday whether it wants the last word on the patentability of Myriad Genetics Inc.'s claims on the BRCA1 and BRCA2 genes, used in diagnostics for breast and ovarian cancer.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription